{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:10:20Z","timestamp":1785550220429,"version":"3.56.0"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,10,16]]},"DOI":"10.1001\/jama.2018.14432","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T18:07:08Z","timestamp":1539713228000},"page":"1548","source":"Crossref","is-referenced-by-count":93,"title":["Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD"],"prefix":"10.1001","volume":"320","author":[{"given":"Graham","family":"Devereux","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom"},{"name":"Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Aintree Chest Centre, University Hospital Aintree, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonaidh","family":"Cotton","sequence":"additional","affiliation":[{"name":"Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Fielding","sequence":"additional","affiliation":[{"name":"Medical Statistics Team, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"McMeekin","sequence":"additional","affiliation":[{"name":"Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Barnes","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Briggs","sequence":"additional","affiliation":[{"name":"Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Royal Victoria Infirmary, Newcastle, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Chaudhuri","sequence":"additional","affiliation":[{"name":"Asthma\/COPD Clinical Research Centre, Gartnavel General Hospital, University of Glasgow, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Chrystyn","sequence":"additional","affiliation":[{"name":"Inhalation Consultancy Ltd, Tarn House, Yeadon, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Davies","sequence":"additional","affiliation":[{"name":"Aintree Chest Centre, University Hospital Aintree, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"De Soyza","sequence":"additional","affiliation":[{"name":"Medical School, Newcastle University, Newcastle Upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gompertz","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Haughney","sequence":"additional","affiliation":[{"name":"Department of Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Innes","sequence":"additional","affiliation":[{"name":"Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kaniewska","sequence":"additional","affiliation":[{"name":"Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Lee","sequence":"additional","affiliation":[{"name":"Medical Statistics Team, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyn","family":"Morice","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Studies, Castle Hill Hospital, Hull, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Norrie","sequence":"additional","affiliation":[{"name":"Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Price","sequence":"additional","affiliation":[{"name":"Department of Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom"},{"name":"Observational and Pragmatic Research Institute, Paya Lebar Square, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"joi180114r1","doi-asserted-by":"publisher","first-page":"020415","DOI":"10.7189\/jogh.05.020415","article-title":"Global and regional estimates of COPD prevalence.","volume":"5","author":"Adeloye","year":"2015","journal-title":"J Glob Health"},{"issue":"11","key":"joi180114r2","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030.","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"issue":"5 Pt 1","key":"joi180114r3","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"joi180114r4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"},{"issue":"13","key":"joi180114r6","doi-asserted-by":"publisher","first-page":"8921","DOI":"10.1073\/pnas.132556899","article-title":"A molecular mechanism of action of theophylline.","volume":"99","author":"Ito","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"joi180114r7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1084\/jem.20040416","article-title":"Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.","volume":"200","author":"Cosio","year":"2004","journal-title":"J Exp Med"},{"issue":"7","key":"joi180114r8","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1164\/rccm.200810-1570OC","article-title":"Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice.","volume":"179","author":"Marwick","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"joi180114r9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1164\/rccm.200906-0937OC","article-title":"Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease.","volume":"182","author":"To","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"joi180114r10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/thx.2008.103432","article-title":"Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD.","volume":"64","author":"Cosio","year":"2009","journal-title":"Thorax"},{"issue":"6","key":"joi180114r11","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1378\/chest.09-2363","article-title":"Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD.","volume":"137","author":"Ford","year":"2010","journal-title":"Chest"},{"issue":"3","key":"joi180114r12","first-page":"206","article-title":"[Patient\u2019 s perspective of chronic obstructive pulmonary disease in Yanqing county of Beijing].","volume":"31","author":"Shen","year":"2008","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"4","key":"joi180114r13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2147\/COPD","article-title":"Geographic differences in clinical characteristics and management of COPD.","volume":"3","author":"Miravitlles","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"joi180114r14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4104\/pcrj.2013.00014","article-title":"Guideline-based COPD management in a resource-limited setting\u2014physicians\u2019 understanding, adherence and barriers: a cross-sectional survey of internal and family medicine hospital-based physicians in Nigeria.","volume":"22","author":"Desalu","year":"2013","journal-title":"Prim Care Respir J"},{"key":"joi180114r15","first-page":"199","article-title":"A study to monitor adverse drug reactions in patients of chronic obstructive pulmonary disease.","volume":"50","author":"Tyagi","year":"2008","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"joi180114r16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13063-015-0782-2","article-title":"Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease.","volume":"16","author":"Devereux","year":"2015","journal-title":"Trials"},{"issue":"6","key":"joi180114r18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD.","volume":"23","author":"Celli","year":"2004","journal-title":"Eur Respir J"},{"issue":"3","key":"joi180114r19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1183\/09031936.00035909","article-title":"Predictive accuracy of patient-reported exacerbation frequency in COPD.","volume":"37","author":"Quint","year":"2011","journal-title":"Eur Respir J"},{"issue":"3","key":"joi180114r20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life.","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"joi180114r22","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/bmj.2.5213.1665","article-title":"Standardised questionnaire on respiratory symptoms.","volume":"2","author":"Fletcher","year":"1960","journal-title":"BMJ"},{"issue":"2","key":"joi180114r23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry.","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"3","key":"joi180114r24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1164\/rccm.201310-1863PP","article-title":"Minimal clinically important differences in pharmacological trials.","volume":"189","author":"Jones","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"joi180114r25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00408-010-9272-1","article-title":"Cough hypersensitivity syndrome.","volume":"189","author":"Morice","year":"2011","journal-title":"Lung"},{"issue":"12","key":"joi180114r26","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease.","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"joi180114r27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/15412555.2012.733463","article-title":"Do we know the minimal clinically important difference (MCID) for COPD exacerbations?","volume":"10","author":"Chapman","year":"2013","journal-title":"COPD"},{"issue":"4","key":"joi180114r28","first-page":"CD003902","article-title":"Oral theophylline for chronic obstructive pulmonary disease.","author":"Ram","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"joi180114r29","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1164\/rccm.201302-0388PP","article-title":"Theophylline.","volume":"188","author":"Barnes","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"joi180114r30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/res.2006.11.issue-5","article-title":"Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.","volume":"11","author":"Zhou","year":"2006","journal-title":"Respirology"},{"issue":"1","key":"joi180114r31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.chest.2016.04.011","article-title":"Oral low-dose theophylline on top of inhaled fluticasone-salmeterol does not reduce exacerbations in patients with severe COPD.","volume":"150","author":"Cos\u00edo","year":"2016","journal-title":"Chest"},{"issue":"2","key":"joi180114r32","first-page":"OC10","article-title":"The study of efficacy, tolerability and safety of theophylline given along with formoterol plus budesonide in COPD.","volume":"9","author":"Subramanian","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"10125","key":"joi180114r33","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S0140-6736(18)30206-X","article-title":"Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"issue":"9971","key":"joi180114r34","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(14)62410-7","article-title":"Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT).","volume":"385","author":"Martinez","year":"2015","journal-title":"Lancet"},{"issue":"13","key":"joi180114r35","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMoa1608033","article-title":"Effectiveness of fluticasone furoate-vilanterol for COPD in clinical practice.","volume":"375","author":"Vestbo","year":"2016","journal-title":"N Engl J Med"},{"key":"joi180114r36","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201712-2493OC","article-title":"Determinants of response to roflumilast in severe copd: pooled analysis of two randomized trials.","author":"Martinez","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"joi180114r37","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.rmed.2007.01.012","article-title":"Effects of an integrated care intervention on risk factors of COPD readmission.","volume":"101","author":"Garcia-Aymerich","year":"2007","journal-title":"Respir Med"},{"issue":"2","key":"joi180114r38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/thx.2005.041806","article-title":"COPD exacerbations, 1: epidemiology.","volume":"61","author":"Donaldson","year":"2006","journal-title":"Thorax"},{"key":"joi180114r5","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD.http:\/\/goldcopd.org\/. Accessed April, 2018."},{"key":"joi180114r17","unstructured":"British National Formulary. Aminophylline.https:\/\/www.medicinescomplete.com\/mc\/bnf\/current\/interactions-of-aminophylline.htm. Accessed July 2, 2018."},{"key":"joi180114r21","unstructured":"CAT Governance Board. COPD assessment test 2016. http:\/\/www.catestonline.org\/. Accessed July 2, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/edhub.ama-assn.org\/journals\/jama\/fullarticle\/2707459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T18:08:35Z","timestamp":1539713315000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.14432"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":38,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,10,16]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.14432","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,16]]}}}